Parametrica Management LTD Incyte Corp Transaction History

Parametrica Management LTD

  • $69.3 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$76.02 - $100.5 $307,348 - $406,321
-4,043 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$80.74 - $97.7 $111,905 - $135,412
-1,386 Reduced 25.53%
4,043 $351,000
Q3 2020

Nov 13, 2020
BUY
$85.07 - $109.69 $461,845 - $595,507
5,429 New
5,429 $488,000

Others Institutions Holding INCY

# of Institutions
618
Shares Held
215M
Call Options Held
366K
Put Options Held
445K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $12.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Parametrica Management LTD Portfolio

Follow Parametrica Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email